Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
234.4 EUR | +0.60% |
|
+0.73% | -18.44% |
28/06 | Would you like some more inflation? | ![]() |
28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENMAB A/S | Bio Therapeutic Drugs | +0.60% | +0.73% | -18.44% | -33.69% | +45.45% | 16.17B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- GE9 Stock
- Charts Genmab A/S
- Comparison Chart